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The possibility that phospholipid deacylation may be 
a critical event in the 12-0-tetradecanoylphorbol-13-
acetate (TPA)-associated effects on mouse skin 
prompted us to examine in vitro the effects of TP A on 
arachidonic acid metabolism in neonatal mouse keratin-
ocytes. Three-day old neonatal keratinocytes were pre-
labeled with p ·'C]arachidonic acid W ''C]AA) and [1 4 C] 
stearic acid ([HC]ST) and used to characterize the li-
pases that were activated when these cells were treated 
with TP A in culture. Data from these studies demon-
strate that phosphatidylcholine (PC) and phosphati-
dylinositol (PI) are the major phospholipids that undergo 
early hydrolysis to release arachidonic acid when chal-
lenged by TP A. Of particular interest was the novel 
observation of the hydrolysis of 1 ''C-labeled PI in these 
keratinocytes, the accumulation of [I'C]l,2-diacylgly-
ceride and the lack of the [I ''C]diacylglyceride phospho-
rylation to form [ 1 4 C]phosphatidic acid. This lack of [ 1 ''C] 
phosphatidic accumulation implied that although TP A 
enhanced the hydrolysis of [ 14C]PI resulting in increased 
[ 14C]diacylglyceride it did not enhance the resynthesis 
of the (14 C]PI via the phosphorylation of the [HC)diacyl-
glyceride. Therefore, TPA probably is not involved in 
the turnover of PI in these cells but is involved in the 
activation of PC hydrolyzing phospholipase A2 and PI 
hydrolyzing phospholipase C in these keratinocytes re-
leasing arachidonic acid which then undergoes oxygen-
ation reactions to provide biologically active eicosa-
noids. 
The topical treatment of mouse skin with phorbol esters such 
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as 12-0-tetradecanoylphorbol-13-acetate (TPA) has been re-
ported to evoke increased epidermal cell proliferation [1- 3]. On 
the other hand, the exposure of epidermal basal cells to TP A 
has been reported to result in divergent responses where some 
cells undergo differentiation and ot hers undergo proliferation 
[ 4]. The reason for these dual effects of TP A on the epidermal 
cells has remained unclear. Furthermore, TPA treatment of 
CD-1 mouse skin has been reported to induce a striking increase 
in prostaglandin E 2 (PGE2) and prostaglandin F2 (PGF20 ) levels 
[5]. TPA has also been reported to enhance the generation of 
PGE2, PGFz,., and prostaglandin D2 (PGD2) by primary cultures 
of murine keratinocytes [6] . The source of the precursor arach-
idonic acid which is the substrate for t hese reported cutaneous 
or cellular prostanoids has remained unknown. 
Reports of TP A involvement in the early stimulatory effects 
of phospho lipid metabolism [7,8] in mouse skin , as well as other 
evidences [9- 13] which implicate the cell surface membrane as 
the primary site of phorbol ester action, stimulated us to 
ascertain in the murine keratinocytes: (i) t he nature of ce llular 
phospholipids that a re responsive to TPA-induced hydrolysis; 
(ii) characte rization of the phospholipases that are activated 
during the phorbol ester treatment; and (iii) to determine 
whether or not TPA treatment of these cells resulted in t he 
alteration of arachidonic acid metabolism via both the cycloox-
ygenase and lipoxygenase pathways. 
MATERIALS AND METHODS 
Mate rial~ 
[1 -"C] a rachidonic ac id (["CJAA ) (58.0 mCi/ rnmol) and [1 -"CJ 
stearic ac id l "C] ST) (5.0 mCi/ mmol) were obta ined from Amersham 
Co rporation. The radio labeled arachidonic ac id was purified by chro-
matography on silicic ac id column (Silicar CC-4) using n -hex· 
ane:diethyl ether (9: 1) as eluting solvent. Additional confirmation of 
purity was by th in -laye r chromatography (TLC). The purity of t he 
purified i"C]AA genera lly exceeded 98%. Nonradioactive sta ndards of 
PGE2, PGD. , PGF2"' thromboxane B2 a nd 6-ketoprostagla ndin -F, , 
were gifts from Dr. Udo Ax en of the Upjohn Co. , Kala mazoo, Michigan. 
The TPA was purchased from PL-Biochemicals , Wisconsin. Reagents 
were of analytical grade. All t he compounds were added in etha nol a t 
a conce nt ration of 0.1% of t he incubation medium. Ethano l at this 
concent ra tion did not inhibi t the act ivi ty of the phospholipases or 
enzymes involved with t he biosynthesis of the eicosanoids. All reagents 
for these experiments were of analytica l grade. 
Cell C u.Ltu res 
Murine keratinocytes were prepared from neo nata l BALB/c mice as 
reported previously [14]. Briefly, freshly dissocia ted keratinocyt.es were 
inoculated into 150-mm T -llasks conta ining M-199 medium wi t h 13% 
feta l ca lf serum , penicillin (50 IU/ m and streptomycin 50 pg/ m l). The 
flasks were gassed with 5% CO. in air , closed, and incubated at 33•c. 
The medium was cha nged every second day. Previous characte ri zations 
of these ce lls showed tha t they were devoid of fibroblasts [ 14 J. 
In corporation of Radiolabeled Precursors into Cellular Phospholipids 
Separate pla tes with 3-day-old ce lls (3.5 X 107 ) were incuba ted with 
I 11 Ci of [" CJAA , an unsaturated fatty acid, or ["C ]ST , a saturated 
fatty acid, in 30 ml of serum -free medium at 37•c for 18 h. At the end 
of the incubation, the medium was aspirated from each plate and t.he 
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ce lls were washed first wi th the medium which conta ined fa tty ac id 
free- BSA (bov ine se rum a lbumin) (0.!) % ) t.o remove nonincorporated 
" C- Iabeled fa tty ac ids, then followed by 2 add it ional washes with the 
medium alone. 
Prior to cha llenging the prelabeled ce ll s with t he tumor promoter, 
fresh medium was added t.o each of t he plates conta in in g the prelabeled 
ce lls. In one se t of experiments, 50 pM of 5,8, 11 ,1:1 -e icosatetraynoic 
ac id (ETYA) an inhibitor of both the cyclooxygenase and lipoxygenase 
pathways, was fir st added to the cultured ce lls foll owed by TPA (3.3 X 
10- • M). The prese nce of E'rY A permits the eva luation of released 
a rachidonic ac id on ly. In another set of experiments t he prelabeled 
ce lls were incubated with the sa me co ncen t ratio n of TPA in culture 
without t he addition of ETY A. Th ese ex per iments permi t evaluation 
of t he oxygenated metaboli tes of released i" C IAA . In both insta nces, 
t he aspirated " C-Iabeled media were ext racted with chl oro-
form :methanol (2:1, v/v) accord ing to t he procedure of Folch et a l !1 5] 
and fractionated on th ~ va rious TLC systems for released i" C]A A and 
t he !" C le icosanoids. 
Extraction of Cellular and Separat ion of 14C-Labeled Cellular Lipids 
At the end of the incubation pe riods, the media were aspirated off 
and t he attached cells washed as descri bed above. The a ttached ce lls 
were ha rvested by scrap in g with a rubber policeman, collected in l ml 
of phosphate-buffe red saline, and homogenized in a Dounce homoge-
nizer. The total lipids we re next extracted with ch loroform:rnethanol 
(2: 1 ). 
Separation o/ " C-La.beled Cellula r Lipids 
T o determine the distr ibution of t he radiolabel in lhe celiula r polar 
and neutra l lipids, the chlorofo rm ext ract from each cell group was 
evapora ted to dryness and redissolved in 50 pi of chlorofo rm:met.hanol 
(1:1 , v/v) which com ained the follow in g authenti c standards of phos· 
pholi pids: phosphatidy lcholine (PC), phosphatidylinos ito l (P I), phos-
phatidylserine (PS), phosphatidyletha nolam ine (PE) and phosphatidic 
ac id (PA ). T he neut ra l lipids used included: I ,2-diacy lglyce ride (OG), 
monoglyce ride (MG) and tr iglyce ride (TG). 
The " C- Iabeled ext rac t containing t he authentic standa rds was 
applied to TLC plates coated with activated extra-pure s ilica gel HR 
and developed in a one-d imens ional system us ing a mixture of ·h loro-
form:melhanol:acetic ac id:wate r (90:8:1:0.8, v/v/v/v} as reported pre -
vious ly 161. Neutra l li p ids were eiTect.ively separated from the phospho-
lipids in th is solve nt system. After visua lizing the nonradioactive 
standards in a tank of iodi ne vapo r, the silica ge l conta inin g the 
radioactive phospholipid fraction was scraped sepa rate ly, elu ted , and 
d ried in a rotary evaporator. The tota l " C- Iabe led phospholipids was 
redissolved in !)0 pi of chloroforrn:met hanol (l :1 , vfv )_ reapplied to a 
newly activated silica gel 1-!R-coa t.ed TLC plate, and separated in a 
seco nd solvent system usi ng chloroform :methanol:acetic acid:water 
(50:30:0.5:3.0, v/v/v/v). T his system effective ly sepa rates the phospho-
lip ids into t heir component pa rts . T he radioact ive neutra l li pid fract ion 
which was collected afte r sepa ration on t he first TLC system was 
furth er sepa rated in a diffe rent solvent system of petro leum 
ether:diethyl ether (70:30, v/v ). The neutra l lipids a re effective ly sep-
a rated in t his system. 
Separa tion of 1' C-Labeled Medium Lipids 
The 14C-labeled medi um lipids extracted from cells culwred wi th 
] 1'CJAA or ]1'C ]ST in t he p rese nce of ETYA and TPA were evaluated 
separately for released 1'C -Iabe led fa tly ac id afte r chromatography with 
authent ic fa tly ac id standa rds on TLC plates in the solvent system 
diethyl et her:petroleum ether:acetic-acid (50: 50: 1) as reported previ-
ously 1 7] . T his system is effective for sepa rating the free fatty acids 
from the noncyclic-hydroxyeicosatetrae noic ac ids . The silica gel on 
each plate was scraped in 5- mm portions directly into scintillation vials 
containing 12 ml of Econolluo r (New England Nuclea r, Boston , Mas-
sachusetts; premi x sc in t illation solution), and t he vials coun ted in a 
Packa rd Tri -Carb sc intillation coun te r. 
T o determine whether 1' C-Iabeled eicosanoids were generated from 
TPA -t reated ce lls previously labeled with I14C]AA, approximately 25 
pg of authent ic standards of PGE2, PGD", and PGF""' including a rach-
idonic acid and a hyd roxy fatty acid, were added to the ext racted 1' C-
Jabeled medium lipids from these experiments as carriers for products 
of both the cyclooxygenase and lipoxygenase pathways. The mixture 
was dried under N2 gas. The dry residue was redissolved in ch loro-
form:m ethanol (1:1), applied to TLC plates coated with s ilica gel G, 
and sepa rated first in the organ ic pbase of solvent mixture of ethyl 
acetate 2,2,4-t.rimethylpentane:acetic ac id:water (82.5:37.5:15:75, v /vI 
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v/v) as desc ribed previous ly [1 6]. This system separates the cyclooxy-
ge nase from lipoxygenase products . Bands of the silica ge l conta ining 
1
' C labe l which com igrated with t he PG s were eluted separately and 
dried under N2 gas. T he elu ted 1' C- Iabeled extract was further separated 
on a one-d imens ional double-development TLC solvent system of ethyl 
acetat.e:acet ic acid (90:1, v/v ). T he silica ge l containing the tota l 1'C-
Iabe led li poxyg-e nase products from the first system was eluted and not 
further fractionated in t hese studies. T he data were therefore presented 
as tota l 14C- Iabeled Ji poxygenase products. 
RESULTS 
Incorporation of [ 1'1C}AA and ( 1'C] ST into Cellular Lipids 
Incubation of the murine keratinocytes with [ 1'C]AA or [1'C] 
ST resulted in the incorporation of both radiolabeled fatty 
acids into the cellula r lipids. Table I shows that 86% of [1'C] 
AA and 58% of [1'1C]ST which were incorporated into the 
cellular lipids we re esterified to ce llular phospholipids. On the 
other hand, on ly 12% of [ ~>~C ] AA and 37% of [1'1C]ST were 
incorporated into the neutral lipids. Sepa ration of t he total 
incorporated 14C label in t he cellular phospholipid fract ion by 
TLC revealed that the percent distribution of both t he t•C-
unsaturated and 14C-saturated labeled fatty acids into t he major 
phospholipids (PC, PE, and PI ) was not significantly different. 
Nonetheless, t he incorporation of [1'C]ST in to PS and PA was 
significant when compared to the unsaturated [HC]AA. Inter-
estingly, analysis of f'4C]AA incorporated into the neutral lipids 
by both unsaturated and saturated fatty ac ids revealed that a 
higher amount of t he unsaturated [1''C]AA was incorporated 
in to t he DG when compared to t he saturated ['"C]ST. Inter-
estingly, more of the saturated [' '1C]ST was incorporated into 
l'"C]triacylglycerol (TG) fraction . 
The Effect of Phorbol Esters on the Hydrolysis of 1'1C- Labeled 
Fatty Acids from the ?relabeled Cells 
In a preliminary experiment, the incubation of cells prela-
beled with [1''C]AA or [14C]ST in a medium containing TPA 
(3.3 X 10-R M) a nd ETY A (50 J.LM) for 60 min resulted in the 
differential release of 14 C label into the incubation medium 
TABLE I. Incorporation af [ 14C}arachidonic acid and { 1'C}stea.ric acid 
into keratt:nocyte cellular lipids 
Distribution Lipids (% of cellular lipids) 
Phospholipid [ 1' C]Arac hidonic ac id: 
Tota l 
PC 
PE 
PI 
PS 
PA 
Neutra l 
Total 
MG 
DC 
TG 
Others 
Phosp holipids 
PC (phosphatidylcholine) 
[86.0 [ 
46.3 
26.0 
19.8 
6.0 
1.9 
[IT] 
16.0 
33.8 
41.2 
9.0 
PE (phosphatidylethanolam ine) 
PI (phosphatidylinositol) 
PA (phosphatidic ac id) 
MG 
DG 
TG 
I14C ]Stearic ac id 
[58.0[ 
46.2 
21.5 
16.3 
12.8 
3.2 
[37.3 [ 
9.0 
19.0 
66.0 
6.0 
Neutral lipids 
(monoacylglyce rol) 
(diacylglyce rol) 
(triacylglyce rol) 
Keratinocytes (3 .5 X 107 ) per 150-mm dish were incubated in a 
cul t ure medium containing either [1 -"C IAA or [1 - " C ]ST overnight 
(18 h) as described under Materials and M ethods. After siphoning off 
t he "C- Jabeled medium , the ce lls were washed and the cells removed 
from t he plates with a rubber policema n. Afte r the extraction of the 
cellula r lipids with chloroform:methanol (2:1 , vfv) the "C-Jabe led phos-
pholipid and 14C-Jabe led neutral lipid were separated by t hin-layer 
chromatography and 14C assayed in a scinti llation counter as described 
under Materials and Methods. T he data are means of duplicate deter-
minat ions from 2 separate experiments and are expressed as percent 
of tota l phospholipids or neut ra l lipids. 
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from the '"C-Iabeled cellular lipids (Fig 1). Approximately 24% 
of the total ["C]AA incorporated into t he cellular lipids was 
released into the medium in ce lls incubated with TPA when 
compared to non-TPA-containing controls. Treatment of t he 
cells prelabeled with [' ''C]ST with TPA, on the other hand, 
released a negligible amoun t of "C label into the medium when 
compared to the non-TPA-containing controls. These data 
implied a positional specificity for TPA action which seemed 
directed toward the 2-position, rather than the 1-position of 
the glycerol moiety of t he ce llular phospholipids. Saturated 
fatty acids are known to be predominantly esterified to the 1-
position of t he glycerol of t he phospholipids. 
In separate experiments the selectivity of TP A as a phorbol 
ester for the keratinocytes was tested by challenging the 14C-
prelabeled cells with another non-tumor-producing phorbol 
diester (4a-phorbol -12,13-didecanoate (4a-PDD)). This phor-
bol este r exerted no cellular release of [14C]AA or ["C]ST from 
the prelabeled cells at s imilar concentrations. 
To delineate which of t he phospholipids are sensitive to 
hydrolysis by TPA in cells prelabeled with [' ''C]AA, we deter-
mined the relative changes in [' ''C]AA of t he 3 major keratin -
ocyte phospholipids (PC, PE, and PI) after incubation of the 
14C -prelabeled cell with TPA. A time-course of the TPA-stim-
ulated changes of ["CJAA in the 3 phospholipids is shown in 
Fig 2. Of particular interest was the loss of ..,C label from [' "C] 
PI as early as 30 min after TPA treatment. At 60 min, release 
of (14C]AA from ["C]PI was approximately 31.2%. On the other 
hand, an early increase in '"C label and no hydrolysis were 
revealed in [' "C]PC and [' ''C]PE at 30 min. This early increase 
was, however, not. sign ificant. At 60 min, hydrolysis of ["C]AA 
from PC was evident and was approximately 20.8%. 
The early and greater Joss of ['"C]AA from [14C]PI prompted 
us to further investigate and compare t he time-course of TPA -
stimulated changes of [' ''C)AA in PA and 1,2-DG (two major 
products of the phosphoinositol cycle). The data in Fig 3 
demonstrated a n increase in [14C]1,2- DG (40%) 30 min after 
TP A challenge of t he ..,C-prelabeled cells and at 60 min "C 
label in this neutral lipid was markedly elevated (192 %). The 
accumulation of ["C]1 ,2-DG correlated with t he loss of [1''C] 
AA from ["C]PI and [' ''C]PC. On the other hand, no sign ificant 
a lteration of '"C label incorporated into (' ''C]PA was detected 
at 30 and 60 min after TPA challenge. These data implied that 
although TPA at 60 min enhanced t he hydrolysis of [' "C]AA 
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FIG L Release of " C-labeled fatty acids from radiolabe led murine 
kerati nocyte by tumor promot.er. Keratinocyt.e~ (3.5 X 107 ) per 150-
mm dish were incubated with either fl -1'1C]AA or [l -14CJST overnight 
(18 h) as described under Materials and Met.hods. The "C-Iabeled 
medium from eac h plate was siphoned ofT the cells, washed twice to 
remove adhering "C label, and then in cubated in fres h medium con-
ta ining ETYA (50 11M) with TPA (:l.~l x Jo-• M ). Control experiments 
we re similar but co ntain ed no TPA. The released "C-Iabeled fatty 
acids were identified after chromatography on TLC with authent.ic 
fatty acids as detic ribed under Materials and Methods. The horizontal 
bars represent means of duplicate determinations from 2 sepa rate 
expe riments and are expre~~ed as percent of " C incorporated into 
cellu lar lipids. 
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FIG 2. Time course of TPA-stimulated changes of i"C]AA levels in 
P , PE, D'ld Pl. I'"C- AA] -labeled keratinocyt.es (3 .5 x 107 ) in l SO- mm 
dishes were incubated with TPA (3.3 x 10-8 M) in the abse nce of 
ETYA, at 37•c for 30 and 60 min. After termination of the incubations 
t.he extracted total cellular "C-labeled lipids were sepa rated in to total 
phospholipid and neutral lipid fractions by TLC, as described under 
Materials and Met.hods for Fig l. The "C label t.hat comigrat.ed with 
the authentic standards of phospholipids was eluted from t.he p la tes, 
dried, and further separated on a fresh TLC plate. The phospholipids 
were separated i1: r he solvent system chloroform:met hanol:acetic acid: 
water (50:30:0.5:3.0, v/ v/ v/v). The data are means of duplicate deter-
minations from separate experiments and are expressed as radioactiv ity 
remaining in the various phospholipids per the number of incubated 
cells. 
from [' ·'C]Pl and [''C]PC, at 60 min it did not stimulate [1 '1C] 
1,2-DG phosphorylation to [' ·'C]PA which is a substrate for 
further transformation back into [' "C]PL 
TPA-Stimulated Generation of Eicosanoids in Cultured 
Murine Keratinocytes 
In the absence of ETYA no significant ['·'C]AA was found to 
accumulate after TP A treatment (results not shown). We t here-
fo re determined whether ["C]AA metabolites were biosynthe-
sized and released into the medium by ce lls cultured in medium 
which contained no ETYA (inhibitor of eicosanoid biosyn -
thesis) . The extracted medium '"C-labeled lipids from these 
experiments was dried under N, gas and then subjected to 
chromatography on activated silica gel G-coated TLC plates 
and deve loped in t he solvent mixtures described under Mate-
n:als and Methods. The data in Table U demonstrate a creneral 
increase in both t he total ~-~c - Jabeled metabolites of the c~c Joox-
yge nase and lipoxygenase pathways. Of particular interest was 
the greate r stimulatory effect of TPA on the metabolism of 
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FIG 3. Comparison of TPA-slimulated changes of I"C]AA levels in 
components of the PI cycle. Expe rimental conditions for separation of 
the phospholipids are as described in legend for Fig 2. The neutral lipid 
fraction was further separated by TLC in the solvent system petroleum 
ether:diethyl ether (70:30, v/v) as described in the text. The data are 
means of duplicate determinations from 2 separate experiments and 
are exp ressed as radioactivity rema ining in lhe phospholipids and 
neutral lipid pe r ::\.5 X 107 ce ll s. 
TABLE 11. Effect of tumor promoter 12-0 -telradecanoylphorbol-13-
acelale on eicosanoid biosynthesis by murine heratinocytes 
Radioactivity (cpm x 10-'; NeL change Eicosanoids 3.5 x 107 cells ) (% of control) 
None IPA 
Cyc\ooxygenase 
Total 3.3 6.8 206.0 
PGE, 1.6 4.1 256.2 
PGFD, 0.6 0.8 133.3 
PFG,, 1.1 1. .9 172.7 
Lipoxygenase 
Total 0.8 2.7 337.5 
Keratinocytes (3.5 X 107 ) per 150-mm dish were incubated wi th ["C] 
AA, TPA (3.3 X 1-8) in the absence of ETYA at 37' C for 60 mi n as 
described in legend for Table I. The "C- Iaheled medium was siphoned 
off and extracted with chloroform:methanol (2:1, vfv). Separation of 
the "C-Iabeled eicosanoids was hy double chromatography on thin· 
layer chromatography plates in solvent system ethyl acetate:acetic acid 
(90:1 v/v). The data are means of duplicate dete rminations fro m 2 
separate experimenls. 
["'C]AA via t he lipoxygenase pathway (>300%) when compared 
to t hat of t he cyclooxygenase pathways (200% ). Fu rthermore, 
the separation of the cyclooxygenase products on TLC plates 
revealed the highest "'C label to be associated wi th PGE2 
(256.2%). 
DISCUSSION 
Data from t hese studies show t hat TP A pert urbation of the 
cellular lipids of t he 3-day-o ld murine kerat inocytes (a popu· 
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lation of predom inant ly basal proliferat ing cells) prev iously 
labeled with [ '''C ]AA resu lted mainly in t he hydrolysis of (14C] 
PC and [' .'C]P l. T he selective hydrolysis of [' .'C]AA (an unsat-
urated fatty acid) and not [' ''C ]ST (a saturated fatty acid} from 
the 14C- labeled phospholipids as shown in F ig 1 implies that 
the posit ional specific ity ofihe TPA action on the kerati nocyte 
phospholipids is directed toward t he 2-posit ion of the glycerol 
moiety of the phospholip ids. Arachidonic ac id is known to be 
predominant ly esterifi ed to t his posit ion of t he phospholipids . 
T he hydrolysis of [' ''C]AA from both PI and PC at 60 min 
after TPA stimulus suggests t he presence of both t he PI-
hydrolyzing phospholipase C as well as t he PC-hydrolyzing 
phospholipiase A2 in t hese ce lls. T he basis for suggesting a 
phospholipase C activity lies on t he novel observation in these 
studies of increased fo rmation of [14C]l ,2-DG , which corre· 
sponded wit h t he loss of [14C]AA from ["C]P l as early as 30 
min (Fig 3}. This early hydrolytic activity suggests t he presence 
of a phospholipase C activ ity in t hese cells. It is unlikely that 
all t he measurable ["C) 1,2-DG observed in t his study was 
de rived from a lipase hydrolysis of t he [' ·'C ]TG, since incorpo-
ration of [14 C]AA into t his neut ral lipid was minimal and was 
not sign ifi cantly altered after TPA t reatment. Furt hermore, 
the lack of (' ''C]PA accumulation (a notable intermediate in 
t he PI cycle} after TPA t reatment of t hese cells implies t hat 
alt hough TPA stimulates t he hydrolysis of [' 4C] AA from ("C) 
PI it did not seem to signi ficantly stimulate the subsequent 
phosphorylation of t he ('''C)1,2-DG into [' 4C]PA . T hus, T PA 
treatment of these cells in cul ture exerts a n early stimulatory 
effect on the hydrolysis of P I which generates 1,2-DG. T he 1,2· 
DC in turn becomes a substrate for a diglyceride lipase hydro· 
lytic activity to yield ("C]MG and (' ''C]AA. T he released [14C] 
AA can t hen un dergo furt her oxygen t ransformations into 
eicosanoids. Since TPA did not enhance t he resynt hesis of PA 
from 1,2-DG in our cul ture system it. is reasonable to speculate 
t hat t he phorbol ester most likely does not modu late P I turn· 
over in t hese epidermal cell s. In addit ion it is interesting that 
TPA treatment of the keratinocytes also resul ted in an early 
moderate inco rporation of [' 4C]AA in to PE and PC. Alt hough 
the elevated •·•c label incorporation in to PC and PE did not 
seem sign ificant from our present studies, t he significance of 
such a fi nding warrants furt her exploration. T he possibility 
that TP A may be involved in t he stimulation of phospholipid 
metabolism in mouse skin [8) and in bovine lymphocytes [18] 
has prev iously been reported. The stimulation of PC turnover 
in HeLa cells has also been described recent ly [19]. 
As shown in Table II , t he t reat ment of t he cultured keratin· 
ocytes by TPA resulted in enhanced biosynthesis of both Ia· 
beled cyclooxygenase and lipoxygenase p roducts and their re· 
lease into t he cul ture medium . T he cellular response of TPA 
as indicated in these studies is consistent wi th elevated p roduc· 
t ion of t he PGE" and PGF2,. which have previously been re· 
ported in mouse epidermis after topical application of T PA [ 5] 
and also in adul t mouse cells previously labeled wit h [14C]AA 
[6). An interesting observation in the T PA effect on t he neo· 
natal mouse keratinocytes, however, is t he ability of phorbol 
ester to influence a greater t ransformation of the released [14C] 
AA into 14C- Iabeled lipoxygenase products. Al t hough t he mech· 
anism and precise '''C-Iabeled lipoxygenase products in our 
preparations still remain to be full y determined, the resul ts , 
nonetheless, imply t hat t he enhancement of products of the 
lipoxygenase pathway may be a mechanism of T PA- induced 
biologic effects on t he mouse epidermal cells. T his conclusion 
is consistent with t he findings of Nakadate et al [20] who 
reported a possible involvement of lipoxygenase product(s} in 
the mechanism of TPA-induced epidermal ODC induction and 
tumor promotion. 
The present studies, part icularly, provide information on t he 
early biochemical events which occur when murine keratino-
cytes are t reated in culture with TPA. Our data provide evi-
dence of t he activation by T PA of both PI-hydrolyzing phos-
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pholipase C and PC-hydrolyzing phospholipase A" at these 
early stages ofTPA a nd keratinocyte interaction. The existence 
of a phospholipase C-hydrolyzing activity is novel in cul tured 
keratinocytes a nd may imply t hat metabolism of other products 
of the inositol cycle such as phosphatidyl inositol, phosphatidyl-
4-phosphate and phosphat idyl-4 ,5-bis-phosphate may also 
function in t he cont rol of cellular responses of these cells. The 
existence of t he polyphosphoryla ted hydrolytic enzymes in 
t hese cells will not only provide arachidonic ac id as substrate 
for the biosynthesis of eicosanoids but also generate important 
inositol phosphates termed "second messengers" which may 
regulate cellular functions. 
The authors express their t hanks to Ms. Karen Castelli for typ ing 
of t he manuscript. 
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